Practical Guide Encompasses Full Range of Treatment For Diabetes and Prediabetes Patients
-- Partnership with Prolacta Bioscience Ensures a Safe, Standardized, and Steady Supply of Pasteurized Donor Milk to Meet Feeding Needs of Premature Infants throughout BayCare Health System
As Rainbow Coral Corp. (OTCBB: RBCC) works to develop new ways to capture a share of the fast-growing, $232 billion personalized medicine market, molecular pathology tests are rapidly transitioning from the laboratory to the clinic.
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its second quarter 2013 financial results on Tuesday, July 23rd, 2013. A copy of the earnings release will be available at http://www.hawkassociates.com.
Digital Angel to Change Name to VeriTeQ Corporation Reflecting Portfolio of Implantable Medical Device Identification and Radiation Therapy Treatments with Multiple FDA Clearances and CE Marks
/PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that Nestle Health Science-Pamlab and Merck & Cie have dismissed their patent litigation against Macoven Pharmaceuticals, LLC., and Breckenridge has dismissed its Lanham Act litigation against Macoven. In return, Macoven has agreed to immediately and permanently cease all manufacturing, use, sale, offers for sale, importation, distribution, advertising, promotion, marketing its generic, unlicensed L-methylfolate calcium salt products. Macoven's discontinued products include: VitaCirc-B, Alz-NAC, L Methylfolate PNV DHA, L-Methylfolate Calcium 7.5, and L-Methylfolate Calcium 15.
ED Patients Using Trimix for Injection Happy They No Longer Carry Ice Packs
The largest privately-held independent oncology/hematology practice in the United States selects VIZZIA's advanced workflow optimization solution to streamline clinical processes and enhance their outpatient experience.
Rainbow Coral Corp. (OTCBB: RBCC) today praised the fundraising results achieved by joint venture partner TheraKine, Ltd., as both companies work together to solve the problems posed by systemic drug delivery.
The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®) is pleased to announce the appointment of Richard Jove, Ph.D., as the new director of the Institute. Dr. Jove will take up his new position beginning July 1, 2013.
/PRNewswire/ -- Biotest Pharmaceuticals Corporation ("BPC"), a wholly owned US subsidiary of Biotest AG, (Dreieich Germany), announced the launch of insPIred™, a comprehensive patient education, resource and support program for the PI community. The inspiration for the program was sparked by the passion and commitment of the Primary Immunodeficiency (PI) community. BPC unveiled the program during the Immune Deficiency Foundation's (IDF) Biannual meeting being held in Baltimore, Maryland.
CHS Pharma Inc., an emerging biotechnology company located in Jupiter, Florida, has announced the addition of Robert S. Langer, Sc.D., to its Board of Directors and Scientific Advisory Board. Langer has made pioneering contributions in drug delivery and regenerative medicine, and together with Judah Folkman, M.D., the founder of the field of angiogenesis, isolated the first substances that stopped blood vessels from growing which led to the first treatment for wet age-related macular degeneration (AMD) and many forms of cancer. Langer is one of 13 institute professors at the Massachusetts Institute of Technology (MIT’s highest honor) and holds more than 800 issued and pending patents. He is the most cited engineer in history with more than 90,000 citations and is the only person to be elected to all four U.S. national academies — Science, Engineering, Inventors, and Medicine, as well as having received the national medal of science and the national medal of technology and innovation.
Oragenics, Inc. (NYSE MKT:OGEN), a healthcare company focused on becoming the world leader in novel antibiotics against infectious disease and probiotcs for oral health, announced today that it will be included in the Russell Microcap Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on Friday, June 28, 2013, according to a preliminary list of additions posted June 21st on www.russell.com/indexes.
Company to Change Name to VeriTeQ Corporation Reflecting Portfolio of Implantable Medical Device Identification and Radiation Therapy Treatments with Multiple FDA Clearances and CE Marks
Strengthens R & D Platform for the Development of Treatments for Metabolic Disorders and Obesity
Hospital using three-dimensional technology to scan brain and neck to prevent stroke
Banyan Biomarkers, Inc. today announced that it has completed a $6 million series A funding from private investors for further biomarker research and continued development of a traumatic brain injury (TBI) diagnostic test. Currently, the company is enrolling subjects in a 2,000 patient pivotal clinical trial funded by a $26.3 million contract with the United States Department of Defense.
The American Association of Clinical Endocrinologists (AACE) applauds the American Medical Association (AMA) House of Delegates for its action today to approve a resolution recognizing obesity as a disease state requiring a range of interventions to advance obesity treatment and prevention. AACE, the sponsor of the resolution, was joined by specialty and state medical societies in advocating for recognition of obesity as a disease state, including The Endocrine Society, American College of Cardiology, American College of Surgeons, American Urological Association, and the Texas State Delegation among many others.
Scientists at the Vaccine & Gene Therapy Institute of Florida (VGTI Florida®) have been awarded three new federal research grants that will further support the Institute’s mission of “Translating Research Into Health®.”
Discusses Company's Unique Business Model and Pipeline of Products
RSS|
My Yahoo|
Newsletters|
Mobile|
Alerts|
Twitter
Terms of Service| Privacy Policy| About our ads| Copyright| About the Miami Herald| About the McClatchy Company| Corrections| Contact Us| Advertise| Work for Us
Partners: El Nuevo Herald| Newspaper in Education| WLRN | Miami Herald News| CBS4 WFOR-TV| More
Copyright 2013 Miami Herald Media Co. All rights reserved
